TP53 and colorectal carcinoma: To further confirm the regulation of CSCs by NR1D2 in CRC, we measured NR1D2 mRNA expression in tissues from a cohort of 196 patients diagnosed with CRC (Table 1) in which we previously evaluated the status of p53 [19].